Release Date: 30/10/20 08:18 Summary: Investor presentation webinar on 4 November Price Sensitive: Yes Download Document 3.76MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%